JESSICA OLIVER: Open Payments
NPI 1316316300 · CASA GRANDE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,125 in 49 payments from 11 companies in 2025. Trend: 2023 $174 · 2024 $602 · 2025 $1,125
Food & beverage: $1,125
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $256 |
| Astellas Pharma US Inc | 7 | $243 |
| ABBVIE INC. | 10 | $212 |
| Amgen Inc. | 14 | $144 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $85 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $61 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Inspire Medical Systems, Inc. | 1 | $31 |
| Novo Nordisk Inc | 1 | $28 |
| PFIZER INC. | 1 | $18 |
Products named: Veozah, BREZTRI, QULIPTA, FARXIGA, OTEZLA, CAPLYTA, MAVYRET, Kerendia.
Industry payments across AZ — which companies pay providers there.
